Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Press Releases

Press Releases Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Criminal Investigations
          Press Releases
          Pharmacist Sentenced for Illegally Dispensing Promethazine Cough Syrup and Earning Millions in ProfitsPress Releases Pharmacist Sentenced for Illegally Dispensing Promethazine Cough Syrup and Earning Millions in Profits
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOCI badge
Department of Justice
U.S. Attorney's Office
Eastern District of Michigan

***FOR IMMEDIATE RELEASE**
Friday, January 12, 2024*

Detroit, MI - Livonia pharmacy owner Zaman Alshafey was sentenced to three years in federal prison by United States District Court Judge Jonathan J.C. Grey following his guilty plea to wire fraud and money laundering. He was also ordered to forfeit approximately $9 million dollars as the gross proceeds of his unlawful conduct, announced United States Attorney Dawn N. Ison.
Ison was joined in the announcement by Special Agent in Charge Ronne Malham, of the Food and Drug Administration.

Alshafey used his pharmacy license and Medpro Pharmacy in Livonia to order more than $2.5 million dollars of pint-sized bottles of promethazine cough syrup from various wholesale distributors who operate outside the State of Michigan. Alshafey then sold the promethazine cough syrup to drug dealers without a valid prescription from a licensed practitioner and he failed to disclose this to the wholesalers. Alshafey paid the wholesalers via wire transfers from funds derived from the unlawful dispensing of the promethazine.
Promethazine is restricted to be dispensed by prescription only per the bottle’s label.

Promethazine cough syrup can have tranquilizing and euphoric effects when consumed at higher-than-recommended dose, especially when mixed with alcohol or other drugs such as fentanyl. Promethazine cough syrup has been referred on the illegal street market as “Green Drink” or “Purple Drink.”
 
“A pharmacist violates the public’s trust by unlawfully dispensing any drug, including promethazine cough syrup,” said U.S. Attorney Ison. “We will continue to prosecute licensed professionals who wantonly engage in conduct that significant harms are community.”
“Providing misbranded prescription drugs puts all consumers’ health at risk,” said Special Agent in Charge Ronne Malham, FDA Office of Criminal Investigations Chicago Field Office. “We will continue to pursue and bring to justice those who jeopardize the public’s health.”
The case was prosecuted by Assistant United States Attorney Regina R. McCullough. Assistant United States Attorney Gjon Juncaj, of the Money Laundering & Asset Recovery Unit handled related forfeiture matters and the investigation was conducted by the Food and Drug Administration.

###

                                                                                  Content current as of:
      01/12/2024Press Releases
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop